Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUND USED AS EGFR KINASE INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/098883
Kind Code:
A1
Abstract:
The present invention relates to a compound used as an EGFR kinase inhibitor and the use thereof. The compound has a structure as shown in formula I, and can be used to adjust the kinase activity or treat related diseases, especially non-small cell lung cancer.

Inventors:
WU YUSHENG (CN)
LI JUN (CN)
NIU CHENGSHAN (CN)
ZHENG MAOLIN (CN)
LIANG APENG (CN)
Application Number:
PCT/CN2020/130948
Publication Date:
May 27, 2021
Filing Date:
November 23, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TYK MEDICINES INC (CN)
International Classes:
C07F9/6558; A61K31/675; A61P35/00
Domestic Patent References:
WO2017086832A12017-05-26
WO2019015655A12019-01-24
WO2019007293A12019-01-10
WO2018108064A12018-06-21
Foreign References:
CN110305161A2019-10-08
CN103153064A2013-06-12
CN106699810A2017-05-24
CN109575045A2019-04-05
CN107698603A2018-02-16
CN102260248A2011-11-30
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: CD7-CAR-T CELL AND PREPARATION AND APPLICATION THEREOF

Next Patent: BELT BREAKAGE PREVENTING BROKEN-CHAIN BELT GRABBING CONVEYOR IMPLEMENTING BELT BREAKAGE PREVENTING B...